Sedentary Interruptions + Exercise for Reducing Type 2 Diabetes Risk in Children
Trial Summary
What is the purpose of this trial?
The overall objective of this in-lab randomized controlled trial is to test the efficacy of multi-day interruptions in sedentary behavior vs. single bouts of sustained exercise on metabolic, cognitive, affective, and cardiac autonomic nervous system responses in children with overweight and obesity who are at risk for type 2 diabetes. The use of continuous glucose monitoring will provide insight into the daily and cumulative metabolic effects of each condition that have thus far not been studied. In-lab studies demonstrating sustained efficacy of this approach in ameliorating negative effects of sedentary behaviors in children are necessary for the optimization of field-based interventions. Given the lack of success of interventions to prevent obesity-related diseases and increasing rates of type 2 diabetes in children and its related healthcare costs, this study addresses a critical public health need by testing of novel intervention strategies to reduce obesity-related diseases in children with overweight and obesity.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those using medications that affect body weight or composition.
What data supports the effectiveness of the treatment for reducing type 2 diabetes risk in children?
Is interrupting sitting with walking safe for children?
How does the SIT+WALK treatment for reducing Type 2 diabetes risk in children differ from other treatments?
The SIT+WALK treatment is unique because it focuses on breaking up long periods of sitting with short bouts of walking, which can improve glucose metabolism in children without changing their diet. This approach is different from traditional treatments that might focus solely on medication or dietary changes.14789
Eligibility Criteria
This trial is for children aged 7-11 who are overweight or obese, with a BMI in the top 15% for their age. They must have normal fasting blood sugar levels and be generally healthy without any significant heart or lung diseases, endocrine disorders like Cushing Syndrome, or treatments affecting body weight.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a fitness test, body composition analysis, and baseline activity and heart rate variability monitoring
Treatment
Participants undergo 7 consecutive days of experimental conditions (SIT, SIT+WALK, or EX) with continuous glucose monitoring and ECG monitoring
Follow-up
Participants are monitored for changes in metabolic, cognitive, affective, and cardiac autonomic nervous system outcomes
Treatment Details
Interventions
- EX (Behavioural Intervention)
- SIT+WALK (Behavioural Intervention)